The largest database of trusted experimental protocols

Caloric Restriction

Caloric Restriction: A dietary regimen that reduces calorie intake without malnutrition.
It has been shown to extend lifespan and improve health outcomes in numerous studies across various species.
PubCompare.ai leverages AI-driven comparisons to help researchers optimize caloric restriction protocols and products, enhancing reproducibility and accuracy for your research findings.
Discover the power of PubCompare.ai and take your caloric restriction studies to the next levle.

Most cited protocols related to «Caloric Restriction»

We designed a randomized clinical trial to compare the effects on body weight of energy-reduced diets that differed in their targets for intake of macronutrients — low or high in fat, average or high in protein, or low or high in carbohydrates — and otherwise followed recommendations for cardiovascular health.29 (link) The trial was conducted from October 2004 through December 2007. An expanded description of the methods is available in the Supplementary Appendix, available with the full text of this article at NEJM.org. The trial was conducted at two sites: the Harvard School of Public Health and Brigham and Women’s Hospital, Boston; and the Pennington Biomedical Research Center of the Louisiana State University System, Baton Rouge. The data coordinating center was at Brigham and Women’s Hospital. The project staff of the National Heart, Lung, and Blood Institute also participated in the development of the protocol, monitoring of progress, interpretation of results, and critical review of the manuscript.
Publication 2009
BLOOD Body Weight Caloric Restriction Carbohydrates Cardiovascular System Heart Lung Macronutrient Intake Proteins Woman
Adult zebrafish (AB line, ZIRC, Eugene, OR, USA) were kept at 28°C under a 14-h light:10-h dark cycle, and water conditions of environmental quality were maintained according to an established protocol [68 ]. Zebrafish at 3.5 mpf were assigned into two dietary groups (overfeeding and maintenance groups) with approximately five fish per 2-L tank. Zebrafish in the overfeeding group were fed three times per day with freshly hatched Artemia (corresponding to 60 mg cysts/fish/day). Zebrafish in the maintenance group were fed freshly hatched Artemia (corresponding to 5 mg cysts/fish/day) once per day. For calorie restriction, the zebrafish were fed freshly hatched Artemia (corresponding to 2.5 mg cysts/fish/day) for 2 weeks after being overfed for 8 weeks. Commercial flake food (Hikari Tropical Fancy Guppy, Kyorin, Hyogo, Japan) consists of 9% fat, 17% carbohydrate and 59% protein, whereas Artemia nauplii consist of 22% fat, 16% carbohydrate and 44% protein (dry weight basis).
The percentage of consumed Artemia was estimated by counting Artemia before and after feeding. Briefly, 1 mL of water was collected from 1700 mL of water containing freshly hatched Artemia corresponding to 100 or 8.5 mg cysts. The numbers of hatched Artemia were counted three times to determine a mean count. After counting, the samples were returned to the 2-L tank. Then, five fish were transferred to the tank for feeding. After 2 hours, the number of Artemia was counted as before feeding. Zebrafish fed 5 or 60 mg of Artemia per day consumed about 80 or 50% of the provided Artemia, respectively. Zebrafish fed 2.5 mg of Artemia per day consumed almost all of the provided Artemia.
Full text: Click here
Publication 2010
Adult Artemia Caloric Restriction Carbohydrates Cyst Diet Fishes Food Kyorin Lebistes Light Proteins Training Programs Zebrafish
Participants were asked to report specific eating disorder behaviors including binge eating, vomiting or laxative use for weight control, weighing one's self on a scale, exercising, skipping a meal, drinking fluids to curb appetite, making sure thighs do not touch, and checking joints and bones for fat. Participants were also asked to report all eating episodes and to indicate whether the episode was a snack, a meal, or a binge. They also indicated whether they felt out of control or driven to eat. Participants were trained in standard definitions of eating events by clinical research staff during the EMA training session. The definition provided to participants for an unusually large amount of food was “an amount of food that most people would consider excessive,” and examples that were tailored to the participants' eating habits were provided. LOC was defined as “the inability to stop eating,” and feeling driven to eat was defined as “the inability to prevent the eating episode.”
The EMA measure of binge eating was defined as a participant endorsing the “binge” option regarding their eating episode. This could be indicated either during the current rating or during a random signal recording (described below) in which the participant indicated that they had binge ate since their last signal. Because reporting a binge eating episode this way may indicate either an objective or subjective binge episode (Fairburn, 2008 ), we will refer to this behavior as LOC eating hereafter. Purging was defined as the participant endorsing either “I vomited” or “I used laxatives for weight control”. Exercise was indicated when a participant endorsed “I exercised” and weighing one's self was similarly reported when a participant endorsed “I weighed myself”. Finally, caloric restriction was recorded at the end of a recording day when the participant endorsed either “I went for eight waking hours without eating” or “I limited daily intake to less than 1200 calories”. We have noted elsewhere that many of the EMA constructs mentioned above converge reasonably well with EDE measurement of similar constructs (Crosby et al., 2012), which supports the validity of the EDE recordings.
Publication 2013
Bones Caloric Restriction Feeding Behaviors Food Joints Laxatives Snacks Thigh Touch
The energy intake required for weight maintenance during baseline and the subsequent energy deficit prescribed to achieve the desired caloric restriction were calculated from 4-week data including two 14-day periods by doubly labeled water (DLW). During the first DLW study (B1) participants followed their usual diet at home. During the second DLW study (B2), participants were provided with a weight maintenance diet. During B2, subjects were weighed every morning and changes in body weight were obtained by regression analysis every 3 days over the 2 week period and energy intake was adjusted as needed to maintain a stable body weight (<±250 g). Values from the animal literature for tissue gain or loss were used to assign energy values to weight changes as previously described [11] (link) and adjustments were made to determine energy intake for weight maintenance. Individual energy requirements were then calculated as the average of total daily energy expenditure (TDEE) during B1 and the final energy intake for weight maintenance (after adjustments) during B2.
Full text: Click here
Publication 2009
Animals Caloric Restriction Diet Energy Metabolism Human Body Tissues
The present case-control study was conducted between January 2019 and March 2020 at King Saud University, Riyadh, Saudi Arabia. Saudi female students aged 18–25 years old with obesity (BMI ≥ 30 kg/m2) or with normal weight (BMI = 18.5–24.9 kg/m2) were invited to participate in the current study through flyers, emails, and word of mouth. Excluded women were those who were pregnant, overweight (BMI = 25.0–29.9 kg/m2), those following specific diets (e.g., calorie-restricted diets), with chronic medical conditions especially gastrointestinal diseases (e.g., colon cancer, inflammatory bowel disease, or acute/chronic diarrhea in the previous eight weeks), oncological or endocrine diseases, anorexia, psychiatric disorders, use of multi-vitamins or vitamin B12, or use of antibiotics during the six months prior to stool sample collection. Of the 400 participants assessed, n = 105 did not meet inclusion criteria and n = 193 did not provide a stool sample. Hence, 102 participants were included in the study, but n = 5 participants were excluded because of inadequate DNA sample concentration and n = 5 were identified as implausible reporters of energy based on the Goldberg equation [19 (link)] and were thus excluded. Thus, a total of 92 Saudi female students were included in the study (48 with normal-weight and 44 with obesity) (Figure S1).
After providing information about the study and obtaining signed consent to participate, along with permission to collect demographic, anthropometric, and biochemical data, including blood and stool samples, each participant was given an appointment to undergo a full assessment at the study clinic. All appointments were booked during the morning period, in which samples were collected at the same time on one day. Participants had the option to withdraw at any stage of the study.
The study protocol was approved by the Institutional Review Board Committee of the Deanship of Scientific Research at King Saud University (IRB #E-19-3625), and all methods were performed in accordance with the Declaration of Helsinki.
Full text: Click here
Publication 2022
Anorexia Antibiotics BLOOD Caloric Restriction Cancer of Colon Chronic Condition Cobalamins Diarrhea Diet Endocrine System Diseases Feces Inflammatory Bowel Diseases Mental Disorders Neoplasms Obesity Oral Cavity Specimen Collection Student Vitamins Woman

Most recents protocols related to «Caloric Restriction»

Not available on PMC !

Example 8

FIG. 10—(A) Effect of NPD1 and VLC-PUFA C32:6 and C34:6 in mediating upregulation of SIRT1 in ARPE-19 cells. (B) Quantification of SIRT1 upregulation by NPD1, C32:6 and C34:6. SIRT1 (Sirtuin1) belongs to a family of highly conserved proteins linked to caloric restriction beneficial outcomes and aging by regulating energy metabolism, genomic stability and stress resistance. SIRT1 is a potential therapeutic target in several diseases including cancer, diabetes, inflammatory disorders, and neurodegenerative diseases or disorders. Elovanoids induce cell survival involving the upregulation of the Bcl2 class of survival proteins and the downregulation of pro-apoptotic Bad and Bax under oxidative stress (OS) in RPE cells. The data in this Figure suggest that elovanoids upregulate SIRT1 abundance in human RPE cells when confronted with OS. As a consequence, remarkable cell survival takes place. This target of elovanoids might be relevant to counteract consequences of several diseases associated with SIRT1.

Full text: Click here
Patent 2024
Anastasis B-Cell Leukemia 2 Family Proteins Caloric Restriction Cells Cell Survival Diabetes Mellitus Energy Metabolism Genomic Stability Homo sapiens Inflammation Malignant Neoplasms Neurodegenerative Disorders Oxidative Stress Polyunsaturated Fatty Acids Sirtuin 1 Staphylococcal Protein A Therapeutics Up-Regulation (Physiology)
This prospective cohort study is based on data collected during the first 2 years of the PREDIMED-Plus (PREvención con DIeta MEDiterránea Plus) study. Briefly, the PREDIMED-Plus study is an ongoing randomized, parallel-group, 6-year multicenter, controlled trial designed to assess the effect of lifestyle interventions on the primary prevention of cardiovascular disease. The primary aim of the trial is to assess the effects of an intensive weight loss intervention based on an energy-reduced Mediterranean diet (MedDiet), physical activity promotion, and behavioral support (intervention group) compared to usual care and dietary counseling only with an energy-unrestricted MedDiet (control group) on the prevention of cardiovascular events. Details of the design and methods of PREDIMED-Plus have been previously described [35 (link), 36 (link)] and are available at https://www.predimedplus.com/.
Full text: Click here
Publication 2023
Caloric Restriction Cardiovascular System Diet Primary Prevention
From January to March 2021, the study was carried out at the Buraydah Central Hospital. This was a repeated-measurement uncontrolled intervention research. The prospective participants listened to a presentation on a very low carbohydrate or ketogenic diet, which provided details of the diet, the significance of nutritional composition, recommended eating times each day, the benefits of the diet, and the high-fat diet. All potential participants were asked to consume a KD for eight weeks while maintaining their normal physical activity levels. The study protocol and potential risks were fully explained to the participants before their written consent was obtained. Participants were asked to attend six sessions during the intervention period, at baseline (pre-intervention), weeks 1, 2, and 4 (mid-intervention), week 6, and week 8 (post-intervention) for an assessment of their body weight, height, BMI, waist circumference, and BHB levels.
The session was held at the Nutrition Clinic of the Buraydah Central Hospital. A very low carbohydrate or ketogenic diet with caloric restriction was used as the experimental intervention. At the start of the intervention, all participants attended a two-hour lecture about a KD, nutritional composition, the proper times to eat, and the beneficial effects of a KD, as well as an educational session about their prescribed diet plan. The participants were given a list of very low-carbohydrate foods to choose from in order to consume 20 g of carbohydrates per day. They were provided with a typical plan and a menu for all main dishes, snacks, and drinks allowed for seven days, with instructions to limit their carbohydrate intake to 5–10% of energy intake (EI) and to derive at least 75% of it from fat, incorporate a protein intake of 20%, and follow a very low-energy diet with a deliberate caloric deficit (1200–1500 kcal). Unlimited quantities of meat, poultry, fish, shellfish, and eggs were permitted, as were two cups of salad and vegetables per day, one cup of low-carbohydrate vegetables per day, four ounces of hard cheese, and limited amounts of cream, avocado, olives, and lemon juice. Transformed fats were prohibited, but fats and oils were not. Detailed explanations of how to apply the KD principles in practice and appropriate tracking and monitoring procedures were provided. The participants were instructed not to use drugs or antioxidants to eliminate the possibility of confounding effects. BHB levels were measured weekly to assess adherence to the dietary regimen.
Full text: Click here
Publication 2023
Antioxidants ARID1A protein, human Body Weight Caloric Restriction Carbohydrates Cheese Citrus limon Diet Diet, High-Fat Eggs Fats Fishes Food Fowls, Domestic Hyperostosis, Diffuse Idiopathic Skeletal Ketogenic Diet Meat Oils Olea Persea americana Pharmaceutical Preparations Salads Shellfish Snacks Staphylococcal Protein A Therapy, Diet Treatment Protocols Vegetables Waist Circumference
The experimental protocols used in the present study were approved by the Institutional Animal Ethics Committee, and the Deanship of Scientific Research, and College of Pharmacy, Qassim University, Saudi Arabia [Approval ID 2020-CP-12] 10137-cavm-2020-1-3-I. Male Sprague–Dawley rats (aged 3 months) were divided into five groups (six rats per group): a control group (NC), diabetes control group (DC), continuous calorie restriction group (CCR), alternate day calorie restriction group (ALT), and a calorie restriction for 2 days group (PF). The control group received an intramuscular (IM) injection of a vehicle (0.5 % w/v carboxyl methyl cellulose sodium). Hyperglycemia was induced in the other groups by an IM injection of STZ (55 mg/kg). The development of hyperglycemia was confirmed by measuring the rats’ blood glucose levels (Accu-Chek Glucometer, Roche, Germany) after 72 h and on day 4 after the last injection. Rats with fasting blood glucose levels higher than 126 mg/dl were considered to be diabetic and used as subjects in further studies [17 (link)]. The four fasting protocols were started after six weeks (Figure 1).
Full text: Click here
Publication 2023
Animals Blood Glucose Caloric Restriction Diabetes Mellitus Hyperglycemia Institutional Ethics Committees Intramuscular Injection Males Methylcellulose Rats, Sprague-Dawley Rattus norvegicus Sodium
Ten-week-old male Wistar rats (n = 40) (bred in the University of Navarra animal facility) were individually housed in a ventilated room (at least 15 complete air changes/h) with relative humidity (50 ± 10%), at a controlled temperature (22 ± 2 °C) and a 12:12 h light–dark cycle (lights on at 8:00 am). Rats were fed ad libitum with a normal chow diet (ND, n = 20) (Diet 2014S, Harlan Laboratories Inc., Barcelona, Spain) or a high-fat diet (HFD, n = 20) (Diet F3282, Bio-Serv, Frenchtown, NJ, USA) for 16 weeks as previously described [27 (link)]. The animals’ weight and food intake were registered on a weekly basis. Rats under ND and HFD were randomly assigned into two groups (n = 10 each) to analyse the effect of a 25% caloric restriction (CR) (ND/CR and HFD/CR). Following all procedures, rats were sacrificed by decapitation after an 8 h fast, and the colon was removed and stored at −80 °C until the next experiments. All experimental protocols adhered to the European Guidelines for the Care and Use of Laboratory Animals (directive 2010/63/EU) and were approved by the Ethics Committee for Animal Experimentation of the University of Navarra (049/10).
Full text: Click here
Publication 2023
Animals Animals, Laboratory Caloric Restriction Colon Decapitation Diet, High-Fat Eating Ethics Committees Europeans Humidity Light Males Rats, Wistar Rattus norvegicus Therapy, Diet

Top products related to «Caloric Restriction»

Sourced in United States, China, Canada, Japan, Denmark, Montenegro, United Kingdom
The D12492 is a powdered rodent diet formulated by Research Diets. It is a highly palatable, nutrient-dense diet that provides a standardized nutritional profile for research purposes. The diet is designed to be easily administered and consumed by laboratory rodents.
Sourced in France, Germany, Denmark, United States, Switzerland
C57BL/6J mice are a common inbred mouse strain that is widely used in biomedical research. They are a robust and well-characterized strain with a stable genetic background. The C57BL/6J mice are known for their docile temperament and are suitable for a variety of research applications.
Sourced in China, United States, Germany, United Kingdom, Canada, Japan, France, Italy, Morocco, Spain, Netherlands, Montenegro, Belgium, Portugal, Ireland, Hungary
The C57BL/6 mouse is a widely used inbred mouse strain. It is a common laboratory mouse model utilized for a variety of research applications.
BALB/cAnNTac is an inbred mouse strain developed and maintained by Taconic Biosciences. This strain is widely used in immunology and cancer research due to its unique genetic characteristics.
Sourced in United States
The B6.129S6-Rag2tm1Fwa N12 is a mouse model produced by Taconic Biosciences. This model has a targeted mutation in the Rag2 gene, which is involved in the development of T and B cells. The core function of this model is to provide a tool for research in areas related to the immune system and immunodeficiency.
Sourced in United States
B6.Cg-Lepob/J (ob/ob) mice are a strain of laboratory mice that have a spontaneous mutation in the leptin (Lep) gene, resulting in obesity, diabetes, and other metabolic abnormalities. These mice are commonly used as an animal model to study obesity, insulin resistance, and related metabolic disorders.
B6.BKS(D)-Leprdb/J (B6 db/db) is a mouse strain that carries a spontaneous mutation in the leptin receptor gene (Leprdb). This mutation results in obesity, hyperglycemia, and insulin resistance, which are characteristic features of type 2 diabetes. The B6 db/db mouse is a widely used model for studying the pathogenesis and potential treatments for metabolic disorders.
Sourced in United States, Montenegro, Japan, Canada, United Kingdom, Germany, Macao, Switzerland, China
C57BL/6J mice are a widely used inbred mouse strain. They are a commonly used model organism in biomedical research.
Sourced in United States, China, United Kingdom, Germany, Australia, Japan, Canada, Italy, France, Switzerland, New Zealand, Brazil, Belgium, India, Spain, Israel, Austria, Poland, Ireland, Sweden, Macao, Netherlands, Denmark, Cameroon, Singapore, Portugal, Argentina, Holy See (Vatican City State), Morocco, Uruguay, Mexico, Thailand, Sao Tome and Principe, Hungary, Panama, Hong Kong, Norway, United Arab Emirates, Czechia, Russian Federation, Chile, Moldova, Republic of, Gabon, Palestine, State of, Saudi Arabia, Senegal
Fetal Bovine Serum (FBS) is a cell culture supplement derived from the blood of bovine fetuses. FBS provides a source of proteins, growth factors, and other components that support the growth and maintenance of various cell types in in vitro cell culture applications.
Sourced in Germany
Acylated ghrelin is a peptide hormone produced by the stomach and other tissues. It plays a key role in the regulation of growth hormone release, appetite, and energy homeostasis.

More about "Caloric Restriction"

Dietary restriction, energy restriction, food restriction, longevity, lifespan, health span, metabolism, inflammation, glucose, lipids, FBS, ghrelin, C57BL/6J, C57BL/6, BALB/cAnNTac, B6.129S6-Rag2tm1Fwa N12, B6.Cg-Lepob/J, B6.BKS(D)-Leprdb/J